A gene locus that controls expression of ACE2 in virus infection

M. Azim Ansari; Emanuele Marchi; Narayan Ramamurthy; Dominik Aschenbrenner; Carl-Philipp Hackstein; - STOP-HCV consortium; - ISARIC-4C Investigators; Shang-Kuan Lin; Rory Bowden; Eshita Sharma; Vincent Pedergnana; Suresh Venkateswaran; Subra Kugathasan; Angela Mo; Greg Gibson; John McLauchlan; Eleanor Barnes; John Kenneth Baillie; Sarah Teichmann; Alex Mentzer; John Todd; Julian Knight; Holm Uhlig; Paul Klenerman.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20080408

Documentos relacionados

  1. Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2.
  2. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
  3. Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection.
  4. Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response.
  5. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
  6. Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.
  7. Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.
  8. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia.
  9. Potential role of IFN-α in COVID-19 patients and its underlying treatment options.
  10. Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.